Ryvu Therapeutics SA(PL:RVU)
zł 17.72+0.52 (+3.02%)
PL:RVU
Ryvu Therapeutics SA earnings date
zł 17.72
At close:+0.52 (+3.02%)
Want to see PL:RVU full AI Analyst Report?
Ryvu Therapeutics SA (RVU) Q2 2021 Earnings Report
0 Followers
PL:RVU Q2 2021 EPS Results
- Actual EPS
- -PLN 1.32
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -PLN 0.27
PL:RVU Q2 2021 Revenue Results
- Actual Revenue
- PLN 309.56K
- Expected Revenue
- PLN 27.87M
- Beat/Miss
- Missed by -PLN 27.56M
- YoY Revenue Growth
- -95.54%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 09/08/2021
- Time
- TBA
- Conference Call
- Wednesday, September 8, 2021
PL:RVU Upcoming Earnings
Ryvu Therapeutics SA's next earnings date is estimated for March 16, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
PL:RVU Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 16, 2027 | 2026 (Q4) | ―- | -0.76 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―- | -1.07 | ― | |
| Sep 17, 2026 | 2026 (Q2) | ―-0.56 | -1.46 | 61.20% (+0.89) | |
| May 20, 2026 | 2026 (Q1) | ―-0.55 | -1.09 | 49.95% (+0.55) | |
| Mar 19, 2026 | 2025 (Q4) | ―-0.76 | -1.52 | 49.80% (+0.76) | |
| Nov 20, 2025 | 2025 (Q3) | ―-1.07 | -1.15 | 6.96% (+0.08) | |
| Sep 18, 2025 | 2025 (Q2) | ―-1.46 | -1.32 | -10.64% (-0.14) | |
| May 21, 2025 | 2025 (Q1) | ―-1.09 | -0.84 | -30.27% (-0.25) | |
| Mar 13, 2025 | 2024 (Q4) | ―-1.52 | -1.2 | -26.33% (-0.32) | |
| Nov 07, 2024 | 2024 (Q3) | ―-1.15 | -0.79 | -45.44% (-0.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
